Skip to main content

Want a detailed portfolio tracker?

vTv Therapeutics (VTVT) P/E (2020 - 2026)

vTv Therapeutics (VTVT) P/E from Mar 31, 2020 to Jul 21, 2026. The TTM vTv Therapeutics (VTVT) P/E is -7.99. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of vTv Therapeutics (VTVT)

YearP/EChange
2026-7.99-17.70%
2025-9.71+201.99%
2024-3.22+277.31%
2023-0.85-46.24%
2022-1.59-53.04%
2021-3.38-48.00%
2020-6.49N/A

Comparison vTv Therapeutics (VTVT) P/E with competitors

vTv Therapeutics (VTVT) P/E is -7.99.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.05%
ENLVEnlivex Ltd0.07-100.94%
FGENFibroGen Inc0.24-103.00%
CHRSCoherus Biosciences Inc0.85-110.62%
FBIOFortress Biotech Inc0.95-111.88%
ORMPOramed Pharmaceuticals Inc1.50-118.81%
AGENAgenus Inc3.01-137.66%
INVAInnoviva Inc3.15-139.47%
CRMDCorMedix Inc3.63-145.40%
CVACCureVac N.V.4.45-155.63%
GLPGGalapagos NV4.86-160.80%
SRPTSarepta Therapeutics Inc4.88-161.09%
ABEOAbeona Therapeutics Inc5.39-167.41%
ABUSArbutus Biopharma Corp5.60-170.02%
ZVRAZevra Therapeutics Inc5.89-173.67%
SPROSpero Therapeutics Inc6.23-177.94%
CGENCompugen Ltd6.31-179.01%
RIGLRigel Pharmaceuticals6.87-185.99%
SLXNSilexion Therapeutics Corp7.30-191.29%
OMEROmeros Corporation9.26-215.85%
AUPHAurinia Pharmaceuticals Inc9.58-219.94%
PLXProtalix BioTherapeutics Inc10.89-236.28%
ACADAcadia Pharmaceuticals Inc11.73-246.76%
TBPHTheravance Biopharma Inc12.26-253.43%
ADMAAdma Biologics Inc12.42-255.39%
HRMYHarmony Biosciences Holdings Inc13.82-272.93%
SABSSAB Biotherapeutics Inc14.14-276.88%
NAGENiagen Bioscience Inc14.82-285.42%
INCYIncyte Corp15.82-297.99%
REGNRegeneron Pharmaceuticals Inc15.86-298.41%
PBYIPuma Biotechnology Inc17.32-316.67%
CPRXCatalyst Pharmaceuticals Inc17.44-318.22%
EXELExelixis Inc17.54-319.45%
TGTXTG Therapeutics Inc18.97-337.32%
MDXGMimedx Group Inc20.55-357.17%
XOMAXOMA Royalty Corp22.87-386.24%
ARGXArgen X SE24.30-404.05%
CTMXCytomX Therapeutics Inc24.82-410.59%
XOMAOXOMA Royalty Corp25.34-417.15%
HALOHalozyme Therapeutics Inc25.62-420.64%
XOMAPXOMA Royalty Corp25.67-421.22%
VRTXVertex Pharmaceuticals Inc27.99-450.30%
RPRXRoyalty Pharma plc - Class A28.69-458.97%
SLNOSoleno Therapeutics Inc29.02-463.08%
ASNDAscendis Pharma A/S30.09-476.47%
LGNDLigand Pharmaceuticals Inc - Class B37.91-574.40%
APLSApellis Pharmaceuticals Inc39.02-588.28%
BMRNBiomarin Pharmaceutical Inc42.21-628.21%
KRYSKrystal Biotech Inc45.34-667.39%
ONCBeiGene Ltd69.54-970.18%
PHARPharming Group N.V.75.03-1038.81%
TECHBio-Techne Corp101.96-1375.83%
VCELVericel Corp109.92-1475.47%
ALNYAlnylam Pharmaceuticals Inc117.96-1576.13%
GMABGenmab140.29-1855.49%
TLXTelix Pharmaceuticals Ltd162.15-2129.06%
CORTCorcept Therapeutics Inc212.86-2763.54%